1. Home
  2. SPRC vs NUWE Comparison

SPRC vs NUWE Comparison

Compare SPRC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • NUWE
  • Stock Information
  • Founded
  • SPRC 2004
  • NUWE 1999
  • Country
  • SPRC Israel
  • NUWE United States
  • Employees
  • SPRC N/A
  • NUWE N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SPRC Health Care
  • NUWE Health Care
  • Exchange
  • SPRC Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • SPRC 3.4M
  • NUWE 3.9M
  • IPO Year
  • SPRC N/A
  • NUWE N/A
  • Fundamental
  • Price
  • SPRC $7.70
  • NUWE $6.57
  • Analyst Decision
  • SPRC
  • NUWE Strong Buy
  • Analyst Count
  • SPRC 0
  • NUWE 1
  • Target Price
  • SPRC N/A
  • NUWE $714.00
  • AVG Volume (30 Days)
  • SPRC 20.1K
  • NUWE 116.8K
  • Earning Date
  • SPRC 02-15-2025
  • NUWE 08-12-2025
  • Dividend Yield
  • SPRC N/A
  • NUWE N/A
  • EPS Growth
  • SPRC N/A
  • NUWE N/A
  • EPS
  • SPRC N/A
  • NUWE N/A
  • Revenue
  • SPRC $1,306,000.00
  • NUWE $8,787,000.00
  • Revenue This Year
  • SPRC N/A
  • NUWE $6.53
  • Revenue Next Year
  • SPRC N/A
  • NUWE $51.63
  • P/E Ratio
  • SPRC N/A
  • NUWE N/A
  • Revenue Growth
  • SPRC N/A
  • NUWE N/A
  • 52 Week Low
  • SPRC $4.14
  • NUWE $6.48
  • 52 Week High
  • SPRC $37.59
  • NUWE $196.98
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 67.65
  • NUWE 25.34
  • Support Level
  • SPRC $6.25
  • NUWE $7.20
  • Resistance Level
  • SPRC $7.17
  • NUWE $10.08
  • Average True Range (ATR)
  • SPRC 0.59
  • NUWE 0.99
  • MACD
  • SPRC 0.10
  • NUWE 0.64
  • Stochastic Oscillator
  • SPRC 88.94
  • NUWE 10.66

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: